Ocular myasthenia gravis and thymoma
Miastenia gravis ocular y timoma
Victor Alegre-Ituarte, Jorge Hernández-Cerdá, Mara Albert-Fort
Keywords
Palabras clave
References
1. Levinson AI, Zweiman B, Lisak RP. Immunopathogenesis and treatment of myasthenia gravis. J Clin Immunol. 1987;7(3):187-97. doi: 10.1007/BF00915723.
2. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(31). doi: 10.1038/s41572-019-0085-0.
3. Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;375(26):2570-81. doi: 10.1056/NEJMra1602678.
4. Bruce BB, Biousse V, Newman NJ. Third nerve palsies. Semin Neurol. 2007;27(3):257-68. doi: 10.1055/s-2007-979681.
5. Mughal M, Longmuir R. Current pharmacologic testing for Horner syndrome. Curr Neurol Neurosci Rep. 2009;9(5):384-9. doi: 10.1007/s11910-009-0056-z.
6. Giannoccaro MP, Paolucci M, Zenesini C, Di Stasi V, Donadio V, Avoni P, et al. Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis. Neurology. 2020;95(13):e1800-e1806. doi: 10.1212/WNL.0000000000010619.
Submitted date:
07/30/2022
Reviewed date:
08/25/2022
Accepted date:
08/31/2022
Publication date:
09/01/2022